Trident Texofab (TTFL) | Stock Overview & Key Data
Trident Texofab Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹379.00 on October 23, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Trident Texofab
TTFL
|
856.11M Small-cap | -7.27% | -17.33% | -40.85% | -88.16% | -83.35% | -78.12% | -29.83% | 17.27% | 1.25% | 1.25% | 1.25% |
|
KPR Mill
KPRMILL
|
317.52B Large-cap | 15.81% | 13.61% | 27.19% | 7.91% | 19.00% | -14.20% | 66.61% | 214.59% | 913.63% | 6,616.47% | 5,793.29% |
| 170.69B Mid-cap | 4.14% | -0.95% | 15.23% | 43.95% | 42.42% | 17.37% | 70.35% | 121.05% | 239.50% | 1,103.15% | 703.61% | |
|
Sanathan Textiles
SANATHAN
|
36.58B Small-cap | -0.31% | -9.37% | 1.37% | -11.78% | -5.83% | -12.75% | 4.47% | 4.47% | 4.47% | 4.47% | 4.47% |
|
Raymond
RAYMOND
|
28.90B Small-cap | -3.20% | 10.73% | 35.39% | 10.03% | 20.99% | -14.21% | -65.70% | 36.29% | 11.45% | 51.80% | 21.23% |
|
Ganesha Ecosphere
GANECOS
|
27.68B Small-cap | -3.70% | -11.34% | 22.86% | 4.50% | 10.83% | -39.83% | -5.32% | 66.07% | 415.03% | 515.67% | 515.67% |
Ownership & Short Interest
Calculate Your Trident Texofab Investment Returns
Long-Term Investment Performance Analysis
Trident Texofab stock price in Oct 2017 was ₹43.20, A ₹1,000.00 lump sum investment in Trident Texofab made 8 years ago would be worth approximately ₹927.55 today, representing a negative return of -7.25%. This translates to an annualized return (CAGR) of -0.86%.
8 Years 8 Months Investment Scenario (Oct 2017 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is TTFL's 52-week high and low?
- In the last 52 weeks, Trident Texofab reached a high of ₹379.00 (on October 23, 2025) and a low of ₹38.57 (on March 19, 2026).
- What is the market cap and P/E ratio for TTFL?
- Curious about Trident Texofab's size and valuation? Its market capitalization stands at 856.11M. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.42, and the forward P/E (looking ahead) is N/A.
- Does TTFL pay dividends? If so, what's the yield?
- As for dividends, Trident Texofab isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Trident Texofab's main competitors or similar companies to consider before investing?
When looking at Trident Texofab, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return KPR Mill
KPRMILL317.52B Consumer Cyclical Textile Manufacturing -14.20% 66.61% Vardhman Textiles
VTL170.69B Consumer Cyclical Textile Manufacturing 17.37% 70.35% Sanathan Textiles
SANATHAN36.58B Consumer Cyclical Textile Manufacturing -12.75% 4.47% Raymond
RAYMOND28.90B Consumer Cyclical Textile Manufacturing -14.21% -65.70% Ganesha Ecosphere
GANECOS27.68B Consumer Cyclical Textile Manufacturing -39.83% -5.32% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Trident Texofab Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Trident Texofab's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.31%, the Debt to Equity ratio from the most recent quarter is 55.71, and its Gross Profit Margin stands at 13.88%.
- What is the recent revenue and earnings growth for TTFL?
- Looking at Trident Texofab's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -18.80%, and quarterly earnings saw a YoY growth of 90.20%.
- How much of TTFL stock is held by insiders and institutions?
- Wondering who owns Trident Texofab stock? Company insiders (like executives and directors) hold about 37.74% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.